Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials

BACKGROUND: Neoadjuvant chemotherapy improves outcome in osteosarcoma. Determination of optimum regimens for survival, toxicity and prognostic factors requires randomised controlled trials to be conducted. PATIENTS AND METHODS: Between 1983 and 2002, the European Osteosarcoma Intergroup recruited 10...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Whelan, J. S., Jinks, R. C., McTiernan, A., Sydes, M. R., Hook, J. M., Trani, L., Uscinska, B., Bramwell, V., Lewis, I. J., Nooij, M. A., van Glabbeke, M., Grimer, R. J., Hogendoorn, P. C. W., Taminiau, A. H. M., Gelderblom, H.
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2012
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3360547/
https://ncbi.nlm.nih.gov/pubmed/22015453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdr491
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares